|
Phospholipid Presenting Particles for Cell Targeting in Therapy and Diagnostics
Reference #: 01594
The University of South Carolina is offering licensing opportunities for Phospholipid Presenting Particles for Cell Targeting in Therapy and Diagnostics
Background:
Current FDA approved controlled/extended-release formulations based on polyesters such as polylactic acid, poly(lactide-co-glycolide), and polycaprolactone do not benefit...
Published: 7/10/2026
|
Updated: 9/13/2022
|
Inventor(s): Kidochukwu Atube, Robert Gower
Keywords(s): cell targeting, drug delivery, emulsion, microparticles, phospholipid, poly(lactide-co-glycolide), polymer particles
Category(s): Biomedical and Life Sciences, Health Sciences
|